X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1902) 1902
Publication (245) 245
Newsletter (62) 62
Book Review (42) 42
Book Chapter (19) 19
Newspaper Article (17) 17
Magazine Article (14) 14
Conference Proceeding (3) 3
Book / eBook (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
zanamivir (1406) 1406
humans (1218) 1218
influenza (855) 855
oseltamivir (742) 742
influenza, human - drug therapy (730) 730
index medicus (702) 702
neuraminidase - antagonists & inhibitors (654) 654
antiviral agents - therapeutic use (652) 652
antiviral agents - pharmacology (462) 462
animals (388) 388
pharmacology & pharmacy (377) 377
female (358) 358
guanidines (356) 356
influenza, human - virology (349) 349
pyrans (344) 344
infectious diseases (342) 342
adult (322) 322
male (309) 309
viruses (308) 308
virology (298) 298
zanamivir - therapeutic use (290) 290
antiviral agents (288) 288
influenza, human - prevention & control (288) 288
oseltamivir - therapeutic use (284) 284
neuraminidase inhibitors (261) 261
zanamivir - pharmacology (241) 241
influenza, human - epidemiology (239) 239
oseltamivir - pharmacology (238) 238
child (235) 235
sialic acids - therapeutic use (235) 235
enzyme inhibitors - pharmacology (232) 232
middle aged (227) 227
microbiology (223) 223
efficacy (222) 222
antiviral agents - administration & dosage (215) 215
drug therapy (210) 210
health aspects (208) 208
enzyme inhibitors - therapeutic use (207) 207
influenza a virus, h1n1 subtype - drug effects (198) 198
drug resistance, viral (197) 197
adolescent (195) 195
neuraminidase - genetics (191) 191
safety (189) 189
virus diseases (188) 188
neuraminidase (179) 179
aged (175) 175
neuraminidase - metabolism (175) 175
medicine, general & internal (168) 168
influenza a virus - drug effects (165) 165
resistance (165) 165
pandemics (164) 164
neuraminidase inhibitor (160) 160
prevention (159) 159
infections (158) 158
influenza viruses (158) 158
infection (155) 155
treatment outcome (155) 155
in-vitro (151) 151
child, preschool (149) 149
immunology (149) 149
antiviral agents - adverse effects (146) 146
mutation (145) 145
research (141) 141
mice (134) 134
analysis (133) 133
amantadine (130) 130
influenza a virus (130) 130
children (129) 129
sialic acids - pharmacology (129) 129
dogs (128) 128
inhibitors (127) 127
cell line (125) 125
influenza b virus - drug effects (120) 120
a virus (117) 117
acetamides - therapeutic use (117) 117
antivirals (116) 116
avian influenza (116) 116
antiviral agents - chemistry (115) 115
infant (114) 114
zanamivir - administration & dosage (114) 114
influenza, human - diagnosis (111) 111
virus (109) 109
drug resistance (108) 108
care and treatment (103) 103
drug resistance, viral - genetics (103) 103
dosage and administration (102) 102
neuraminidase - chemistry (102) 102
influenza a virus, h1n1 subtype - genetics (99) 99
neuraminidase inhibitor zanamivir (99) 99
young adult (99) 99
chemistry, medicinal (98) 98
peramivir (98) 98
influenza a virus, h1n1 subtype - isolation & purification (95) 95
influenza vaccines (95) 95
randomized controlled-trial (95) 95
drug design (92) 92
oseltamivir phosphate (92) 92
vaccination (89) 89
epidemics (88) 88
influenza a virus, h1n1 subtype (88) 88
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1858) 1858
Japanese (35) 35
French (27) 27
German (26) 26
Spanish (17) 17
Chinese (11) 11
Russian (10) 10
Italian (6) 6
Dutch (5) 5
Korean (4) 4
Swedish (4) 4
Polish (3) 3
Danish (2) 2
Slovenian (2) 2
Croatian (1) 1
Finnish (1) 1
Icelandic (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Cochrane database of systematic reviews, ISSN 1469-493X, 2014, Volume 4, Issue 4, pp. CD008965 - CD008965
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 02/2014, Volume 209, Issue 4, pp. 542 - 550
Journal Article
Expert Review of Anti-Infective Therapy, ISSN 1478-7210, 04/2015, Volume 13, Issue 4, pp. 417 - 425
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 11/2016, Volume 123, pp. 397 - 406
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2013, Volume 8, Issue 4, p. e60348
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 03/2018, Volume 217, Issue 6, pp. 887 - 896
Background. Treatment of immunocompromised, influenza virus-infected patients with the viral neuraminidase inhibitor oseltamivir often leads to the emergence... 
Neuraminidase inhibitor | Combination therapy | Drug resistance | Polymerase inhibitor | Influenza | influenza | DRUG | FAVIPIRAVIR | INFECTIOUS DISEASES | polymerase inhibitor | MICROBIOLOGY | LANINAMIVIR | IMMUNOLOGY | EMERGENCE | neuraminidase inhibitor | IN-VITRO | A(H1N1) | OSELTAMIVIR-RESISTANT | T-705 | combination therapy | ZANAMIVIR RESISTANCE | drug resistance | MUTATIONS | Oseltamivir - therapeutic use | Pyrazines - administration & dosage | Pyrazines - therapeutic use | Dose-Response Relationship, Drug | Enzyme Inhibitors - administration & dosage | Lung - virology | Zanamivir - analogs & derivatives | Female | Drug Therapy, Combination | Orthomyxoviridae Infections - drug therapy | Nucleic Acid Synthesis Inhibitors - therapeutic use | Lung - pathology | Antiviral Agents - therapeutic use | Nucleic Acid Synthesis Inhibitors - administration & dosage | Amides - therapeutic use | Influenza A Virus, H1N1 Subtype - drug effects | Antiviral Agents - administration & dosage | Enzyme Inhibitors - therapeutic use | Zanamivir - therapeutic use | Animals | Mice, Nude | Oseltamivir - administration & dosage | Zanamivir - administration & dosage | Neuraminidase - antagonists & inhibitors | Mice | Mice, Inbred BALB C | Immunocompromised Host | Amides - administration & dosage | Orthomyxoviridae Infections - virology
Journal Article